Analysis of the inhibition potential of zosuquidar derivatives on selected bacterial and fungal ABC transporters

Molecular Membrane Biology

Volumn 30, Issue 2, 2013, Pages 217-227

  Infed, Nacera ^a   Smits, Sander H J ^a   Dittrich, Torsten ^a   Braun, Manfred ^a   Driessen, Arnold J M ^b   Hanekop, Nils ^a   Schmitt, Lutz ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

ABC transporter; Inhibitor; Multidrug resistance; Pleiotropic drug resistance; Transport; Zosuquidar

Indexed keywords

ABC TRANSPORTER; LEAD; RHODAMINE 6G; ZOSUQUIDAR;

ARTICLE; DIASTEREOISOMER; DRUG INHIBITION; IC 50; LACTOCOCCUS LACTIS; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; STRUCTURE ACTIVITY RELATION;

ADENOSINE TRIPHOSPHATASES; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; BENZIMIDAZOLES; BIOLOGICAL TRANSPORT; DIBENZOCYCLOHEPTENES; DRUG RESISTANCE, MULTIPLE; FUNGAL PROTEINS; LACTOCOCCUS LACTIS; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; QUINOLINES; RHODAMINES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 84873050654     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.3109/09687688.2012.758876     Document Type: Article

References (37)

1. Balakrishnan L, Venter H, Shilling RA, Van Veen HW. 2004. Reversible transport by the ATP-binding cassette multidrug export pump LmrA: ATP synthesis at the expense of downhill ethidium uptake. J Biol Chem 279:11273-11280.
2. Baykov AA, Evtushenko OA, Avaeva SM. 1988. A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal Biochem 171:266-270.
3. Conseil G, Decottignies A, Jault JM, Comte G, Barron D, Goffeau A, et al. 2000. Prenyl-flavonoids as potent inhibitors of the Pdr5p multidrug ABC transporter from Saccharomyces cerevisiae. Biochemistry 39:6910-6917.
4. Conseil G, Perez-Victoria JM, Renoir JM, Goffeau A, Di Pietro A. 2003. Potent competitive inhibition of drug binding to the Saccharomyces cerevisiae ABC exporter Pdr5p by the hydro-phobic estradiol-derivative RU49953. Biochim Biophys Acta 1614:131-134.
5. Dantzig AH, Law KL, Cao J, Starling JJ. 2001. Reversal of mul-tidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic. Curr Med Chem 8:39-50.
6. Dittrich T, Hanekop N, Infed N, Schmitt L, Braun M. 2012. Synthesis of 5-oxyquinoline derivatives for reversal multidrug resistance. Beilstein J. Org. Chem 8:1700-1704.
7. Egner R, Rosenthal FE, Kralli A, Sanglard D, Kuchler K. 1998. Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter. Mol Biol Cell 9:523-543.
8. Ernst R, Kueppers P, Klein CM, Schwarzmueller T, Kuchler K, Schmitt L. 2008. A mutation of the H-loop selectively affects rhodamine transport by the yeast multidrug ABC transporter Pdr5. Proc Natl Acad Sci USA 105:5069-5074.
9. Fukazawa N, Odate M, Suzuki T, Otsuka K, Tsuruo T, Sato W. 1990. Preparation of heterocyclic compounds as anti-cancer drug potentiators. EP 363212.
10. Fukazawa N, Suzuki T, Otsuka K, Yano O, Sato W, Tsuruo T. 1992. Newquinolines,theirpreparations,andanticanceractivityenhan-cers containing the quinolines. Japanese patent 04235983.
11. Golin J, Ambudkar SV, Gottesman MM, Habib AD, Sczepanski J, Ziccardi W, et al. 2003. Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic efflux. J Biol Chem 278:5963-5869.
12. Gottesman MM, Fojo T, Bates SE. 2002. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev Cancer 2:48-58.
13. Heller DP, Greenstock CL. 1994. Fluorescence lifetime analysis of DNA intercalated ethidium bromide and quenching by free dye. Biophys Chem 50:305-312.
14. Kolaczkowski M, Van Der Rest M, Cybularz-Kolaczkowska A, Soumillion JP, KoningsWN,GoffeauA.1996.Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p. J Biol Chem 271:31543-31548.
15. Lubelski J, De Jong A, Van Merkerk R, Agustiandari H, Kuipers OP, Kok J, et al. 2006a. LmrCD is a major multidrug resistance transporter in Lactococcus lactis. Mol Microbiol 61:771-781.
16. Lubelski J, Konings WN, Driessen AJ. 2007. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Microbiol Mol Biol Rev 71:463-476.
17. Lubelski J, Mazurkiewicz P, Van Merkerk R, Konings WN, Driessen AJ. 2004. ydaG and ydbA of Lactococcus lactis encode a heterodimeric ATP-binding cassette-type multidrug transporter. J Biol Chem 279:34449-34455.
18. Lubelski J, Van Merkerk R, Konings WN, Driessen AJ. 2006b. Nucleotide-binding sites of the heterodimeric LmrCD ABC-multidrug transporter of Lactococcus lactis are asymmetric. Biochemistry 45:648-656.
19. Morschhauser J. 2010. Regulation of multidrug resistance in pathogenic fungi. Fungal Genet Biol 47:94-106.
20. Pfister JR, Lynne SD. 1994. 10,11-Methanodibenzosuberane derivatives used as chemosensitizing agents.
21. Pfister JR, Makra F, Muehldorf AV, Wu H, Nelson JT, Cheung P, et al. 1995. Methanodibenzosuberylpiperazines as potent multidrug-resistance reversal agents. Bioorgan Medic Chem Lett 5:2473-2476.
22. Piddock LJ. 2006a. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19:382-402.
23. Piddock LJ. 2006b. Multidrug-resistance efflux pumps-not just for resistance. Nat Rev Microbiol 4:629-636.
24. Prasad R, De Wergifosse P, Goffeau A, Balzi E. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27:320-329.
25. Sanglard D, Coste A, Ferrari S. 2009. Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 9:1029-1050.
26. Shapiro AB, Ling V. 1995. Reconstitution of drug transport by purified P-glycoprotein. J Biol Chem 270:16167-16175.
27. Shapiro AB, Ling V. 1997. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur J Biochem 250:130-137.
28. Sircar I, Haleen SJ, Burke SE, Barth H. 1992. Synthesis and biological activity of 4-(diphenylmethyl)-alpha-[(4-quinoliny-loxy)methyl]-1- piperazineethanol and related compounds. J Med Chem 35:4442-4449.
29. Sorbera LA, Castaner J, Silvestre JS, Bayes M. 2003. Zosuquidar trihydrochloride-multidrug resistance modulator P-glycopro-tein (MDR-1) inhibitor. Drugs Future 28:125-136.
30. Starling JJ, Shepard RL, Cao J, Law KL, Norman BH, Kroin JS, et al. 1997. Pharmacological characterization of LY335979: A potent cyclopropyldibenzosuberane modulator of P-glycoprotein. Adv Enzyme Regul 37:335-347.
31. Suzuki T, Fukazawa N, San-Nohe K, Sato W, Yano O, Tsuruo T. 1997. Structure-activity relationship of newly synthesized quin-oline derivatives for reversal of multidrug resistance in cancer. J Med Chem 40:2047-2052.
32. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. 2006. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219-234.
33. Van Den Berg van Saparoea HB, Lubelski J, Van Merkerk R, Mazurkiewicz PS, Driessen AJ. 2005. Proton motive force-dependent Hoechst 33342 transport by the ABC transporter LmrA of Lactococcus lactis. Biochemistry 44:16931-16938.
34. Van Veen HW, Callaghan R, Soceneantu L, Sardini A, Konings WN, Higgins CF. 1998. A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene. Nature 391:291-295.
35. Van Veen HW, Margolles A, Muller M, Higgins CF, Konings WN. 2000. The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism. EMBO J 19:2503-2514.
36. Van Veen HW, Venema K, Bolhuis H, Oussenko I, Kok J, Poolman B, et al. 1996. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc Natl Acad Sci USA 93:10668-10672.
37. Venter H, Velamakanni S, Balakrishnan L, Van Veen HW. 2008. On the energy-dependence of Hoechst 33342 transport by the ABC transporter LmrA. Biochem Pharmacol 75:866-874.